Amylin Pharmaceuticals

News across the web »
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

107766 Followers

Web Messenger

Platinum Member

107766 Followers

Related News »
Amylin Pharmaceuticals Inc. (AMLN), the diabetes drugmaker that has put itself up for sale, received offers from Sanofi (SAN) and Merck & Co. in an initial round of bidding, said three people familiar with the process. The companies made bids of ...
May 26, 2012 at 04:35 | Source: Bloomberg
HONG KONG — Today, www.BrightonMarkets.com announced new reports highlighting Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) and Wal-Mart Stores, Inc. (NYSE: WMT). Gain market insight with full analysis and research downloads available at www ...
May 25, 2012 at 12:57 | Source: msnbc.com
Amylin Pharmaceuticals's stock is down 3.3% to $25.81 on heavy trading volume. Approximately 4.3 million shares have changed hands today vs. average 30-day volume of 3.4 million shares. Unusually high volume can signify a potential turning point or ...
May 23, 2012 at 18:00 | Source: Financial News Network Online
Here are stocks that are up on high volume: Sara Lee (SLE) experienced a price hike on above-average volume today, trading at a volume of 14 million, or 1.6 times its standard daily volume. The stock price was up 1.7% to $21.19. Share price rose ...
May 25, 2012 at 19:02 | Source: FOXBusiness
Wednesday, May 23, 2012... Closing out the day... Stocks finished narrowly mixed after spending a majority of the day solidly in the red. Worries about Greece leaving the..... Friday, May 18, 2012... Amylin Pharmaceuticals Inc (NASDAQ: AMLN) closed ...
May 14, 2012 at 11:52 | Source: Market Intelligence Center
Amylin Pharmaceuticals Inc. (AMLN) (AMLN) has lured suitors such as Pfizer Inc. (PFE) (PFE), AstraZeneca Plc (AZN) and Sanofi, which signed confidentiality agreements on the drugmaker’s sale process, said people familiar with the matter.
May 14, 2012 at 23:55 | Source: Businessweek
May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter. Merck & Co ...
May 15, 2012 at 14:49 | Source: San Francisco Gate
Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform. Amylin Pharmaceuticals ...
May 16, 2012 at 11:35 | Source: Financial News Network Online
On May 15, 2012, the stockholders of Amylin Pharmaceuticals, Inc., or Amylin, voted to approve an amendment to Amylin's 2009 Equity Incentive Plan, or 2009 EIP, to increase by 12,000,000 shares the aggregate number of shares of Amylin's common stock ...
May 16, 2012 at 19:27 | Source: Yahoo! Finance
For a company that owes about 45% of its post-March 28 market cap to buyout rumors, biopharma Amylin Pharmaceuticals (AMLN) continues to be stubbornly silent on the question of whether or not the company is for sale, at what price, and potentially to whom.
May 16, 2012 at 06:06 | Source: Seekingalpha.com